128 related articles for article (PubMed ID: 37815002)
1. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
[TBL] [Abstract][Full Text] [Related]
2. TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
Vinothkumar V; Arunkumar G; Revathidevi S; Arun K; Manikandan M; Rao AK; Rajkumar KS; Ajay C; Rajaraman R; Ramani R; Murugan AK; Munirajan AK
Tumour Biol; 2016 Jun; 37(6):7907-13. PubMed ID: 26700669
[TBL] [Abstract][Full Text] [Related]
3. TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Giunco S; Rampazzo E; Brutti M; Spinato G; Menegaldo A; Stellin M; Mantovani M; Bandolin L; Rossi M; Del Mistro A; Tirelli G; Dei Tos AP; Guerriero A; Niero M; Da Mosto MC; Polesel J; De Rossi A
J Cancer Res Clin Oncol; 2020 Feb; 146(2):381-389. PubMed ID: 31960186
[TBL] [Abstract][Full Text] [Related]
4.
Yu Y; Fan D; Song X; Zakeri K; Chen L; Kang J; McBride S; Tsai CJ; Dunn L; Sherman E; Katabi N; Dogan S; Cracchiolo J; Cohen M; Boyle JO; Lee M; Valero C; Wang J; Wong R; Morris L; Riaz N; Lee N
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34381934
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance.
Boscolo-Rizzo P; Tirelli G; Polesel J; Sia E; Phillips V; Borsetto D; De Rossi A; Giunco S
Oral Oncol; 2023 May; 140():106398. PubMed ID: 37075587
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
[TBL] [Abstract][Full Text] [Related]
7. Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
Annunziata C; Pezzuto F; Greggi S; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
Int J Cancer; 2018 Sep; 143(5):1153-1161. PubMed ID: 29603728
[TBL] [Abstract][Full Text] [Related]
8. Examining the contribution of smoking and HPV towards the etiology of oral cavity squamous cell carcinoma using high-throughput sequencing: A prospective observational study.
Zammit AP; Sinha R; Cooper CL; Perry CFL; Frazer IH; Tuong ZK
PLoS One; 2018; 13(10):e0205406. PubMed ID: 30308005
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma.
Chang KP; Wang CI; Pickering CR; Huang Y; Tsai CN; Tsang NM; Kao HK; Cheng MH; Myers JN
Head Neck; 2017 Jun; 39(6):1131-1137. PubMed ID: 28230921
[TBL] [Abstract][Full Text] [Related]
10. Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma.
Yilmaz I; Erkul BE; Ozturk Sari S; Issin G; Tural E; Terzi Kaya Terzi N; Karatay H; Celik M; Ulusan M; Bilgic B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jul; 130(1):63-70. PubMed ID: 32404253
[TBL] [Abstract][Full Text] [Related]
11. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
[TBL] [Abstract][Full Text] [Related]
12. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
15. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
16. RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells.
Xiang Z; Zhou S; Liang S; Zhang G; Tan Y
J Oral Pathol Med; 2020 Sep; 49(8):741-750. PubMed ID: 32306431
[TBL] [Abstract][Full Text] [Related]
17. Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.
Al-Swiahb JN; Chen CH; Chuang HC; Fang FM; Tasi HT; Chien CY
Future Oncol; 2010 May; 6(5):837-50. PubMed ID: 20465394
[TBL] [Abstract][Full Text] [Related]
18. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract][Full Text] [Related]
19. What has the National Cancer Database taught us about oral cavity squamous cell carcinoma?
Graillon N; Iocca O; Carey RM; Benjamin K; Cannady SB; Hartner L; Newman JG; Rajasekaran K; Brant JA; Shanti RM
Int J Oral Maxillofac Surg; 2022 Jan; 51(1):10-17. PubMed ID: 33840565
[TBL] [Abstract][Full Text] [Related]
20. TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Erkul E; Yilmaz I
Oral Oncol; 2021 Mar; 114():105089. PubMed ID: 33189577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
